These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37668030)

  • 1. [Application of Preschool Auditory Processing Assessment Scale in children with attention deficit hyperactivity disorder].
    Sun YY; Zhu HQ; Liu PT; Lin HX; Xiao ZL; Yu XY; Qian J; Chi X; Hong Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Aug; 25(8):824-830. PubMed ID: 37668030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Results of a multicentre double-blind randomised placebo-controlled clinical trial evaluating the efficacy and safety of Mexidol in the treatment of Attention Deficit Hyperactivity Disorder in Children (MEGA)].
    Zavadenko NN; Suvorinova NY; Batysheva TT; Bykova OV; Platonova AN; Gaynetdinova DD; Levitina EV; Mashin VV; Vakula IN; Maximova NE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(4):75-86. PubMed ID: 35485068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High pretreatment cognitive impulsivity predicts response of oppositional symptoms to methylphenidate in patients with attention-deficit hyperactivity disorder/oppositional defiant disorder.
    Golubchik P; Shalev L; Tsamir D; Manor I; Weizman A
    Int Clin Psychopharmacol; 2019 May; 34(3):138-142. PubMed ID: 30640748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental Validity of Multi-Method and Multi-Informant Evaluations in the Clinical Diagnosis of Preschool ADHD.
    Chen IC; Lee PW; Wang LJ; Chang CH; Lin CH; Ko LW
    J Atten Disord; 2022 Aug; 26(10):1293-1303. PubMed ID: 34949123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of quantitative electroencephalography and Integrated Visual and Auditory Continuous Performance Test as auxiliary tools for the Attention Deficit Hyperactivity Disorder diagnosis.
    Kim J; Lee Y; Han D; Min K; Kim D; Lee C
    Clin Neurophysiol; 2015 Mar; 126(3):532-40. PubMed ID: 25088931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Behavior Rating Inventory of Executive Function and Continuous Performance Test in Preschoolers with Attention Deficit Hyperactivity Disorder.
    Çak HT; Çengel Kültür SE; Gökler B; Öktem F; Taşkıran C
    Psychiatry Investig; 2017 May; 14(3):260-270. PubMed ID: 28539944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intelligibility of degraded speech and the relationship between symptoms of inattention, hyperactivity/impulsivity and language impairment in children with suspected auditory processing disorder.
    Ahmmed AU
    Int J Pediatr Otorhinolaryngol; 2017 Oct; 101():178-185. PubMed ID: 28964292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parent SNAP-IV rating of attention-deficit/hyperactivity disorder: accuracy in a clinical sample of ADHD, validity, and reliability in a Brazilian sample.
    Costa DS; de Paula JJ; Malloy-Diniz LF; Romano-Silva MA; Miranda DM
    J Pediatr (Rio J); 2019; 95(6):736-743. PubMed ID: 30236592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the Conners' Continuous Performance Test aid in ADHD diagnosis?
    McGee RA; Clark SE; Symons DK
    J Abnorm Child Psychol; 2000 Oct; 28(5):415-24. PubMed ID: 11100916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder.
    Childress AC; Kollins SH; Foehl HC; Newcorn JH; Mattingly G; Kupper RJ; Adjei AL
    J Child Adolesc Psychopharmacol; 2020 Mar; 30(2):58-68. PubMed ID: 32125903
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II/III Study of Lisdexamfetamine Dimesylate in Japanese Pediatric Patients with Attention-Deficit/Hyperactivity Disorder.
    Ichikawa H; Miyajima T; Yamashita Y; Fujiwara M; Fukushi A; Saito K
    J Child Adolesc Psychopharmacol; 2020 Feb; 30(1):21-31. PubMed ID: 31718254
    [No Abstract]   [Full Text] [Related]  

  • 12. A Counting Stroop Functional Magnetic Resonance Imaging Study on the Effects of ORADUR-Methylphenidate in Drug-Naive Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Chou TL; Hsieh CY; Gau SS
    J Child Adolesc Psychopharmacol; 2022 Nov; 32(9):467-475. PubMed ID: 36251766
    [No Abstract]   [Full Text] [Related]  

  • 13. A virtual reality application for assessment for attention deficit hyperactivity disorder in school-aged children.
    Fang Y; Han D; Luo H
    Neuropsychiatr Dis Treat; 2019; 15():1517-1523. PubMed ID: 31239686
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months.
    Wang LJ; Huang YS; Chiang YL; Hsiao CC; Shang ZY; Chen CK
    BMC Psychiatry; 2011 Apr; 11():65. PubMed ID: 21504587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation tools of the characteristics of attention deficit and hyperactivity disorder (ADHD) in children and adolescents: A literature review].
    Gamvrouli M; Gamvrouli I; Triantafyllou C
    Psychiatriki; 2023 Jul; 34(2):112-121. PubMed ID: 34390561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Open-Label, Randomized Trial of Methylphenidate and Atomoxetine Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Shang CY; Pan YL; Lin HY; Huang LW; Gau SS
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):566-73. PubMed ID: 26222447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between sleep disorders and attention-deficit-hyperactivity disorder in children.
    Yin H; Yang D; Yang L; Wu G
    Front Pediatr; 2022; 10():919572. PubMed ID: 35935380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.
    Connor DF; Findling RL; Kollins SH; Sallee F; López FA; Lyne A; Tremblay G
    CNS Drugs; 2010 Sep; 24(9):755-68. PubMed ID: 20806988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors affecting therapeutic effect of ADHD treated by optimal dose of methylphenidate].
    Yang L; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 39(3):284-8. PubMed ID: 17572785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Lisdexamfetamine in Preschool Children With Attention-Deficit/Hyperactivity Disorder.
    Childress AC; Lloyd E; Jacobsen L; Gunawardhana L; Johnson SA; Findling RL
    J Am Acad Child Adolesc Psychiatry; 2022 Dec; 61(12):1423-1434. PubMed ID: 35577034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.